Back
MoonLake Immunotherapeutics Stock Predictions
Should You Invest in this AI Marketing High-Growth Startup by April?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
11
MLTX
MoonLake Immunotherapeutics
Last Price:
$38.45
Seasonality Move:
-6.98%
7 Day Trial
ALL ACCESS PASS
$
7
Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.MoonLake Immunotherapeutics Stock Forecast
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 52.8% based on the past 4 years of stock performance.
-
MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is MoonLake Immunotherapeutics Stock Undervalued?The current MoonLake Immunotherapeutics [MLTX] share price is $38.67. The Score for MLTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
MLTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 52.8% based on the past 4 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Sell
11
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics overpriced?
-
MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
58.26
52-Week Low:
36.52
Prediction Charts
Market Cap:
2.4B
Price in USD:
38.67
Volume:
300.2K
Beta:
1.32
Technical Analysis
SMA50:
44.67
SMA100:
47.86
SMA200:
46.84
52-Wk Change:
-11.67%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?Yes, MoonLake Immunotherapeutics is a publicly traded company.
-
What is the MoonLake Immunotherapeutics stock quote today?The MoonLake Immunotherapeutics stock price is 38.67 USD today.
-
How to buy MoonLake Immunotherapeutics stock online?You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-21 | 42.54 | 42.33 | 43.06 | 42.10 |
| Feb-25 | 40.88 | 40.73 | 41.36 | 39.87 |
| Feb-26 | 40.07 | 42.37 | 42.91 | 40.04 |
| Feb-27 | 41.93 | 41.84 | 43.41 | 41.78 |
| Feb-28 | 42.12 | 41.76 | 42.56 | 40.66 |
| Mar-3 | 41.75 | 39.63 | 42.51 | 39.61 |
| Mar-4 | 39.50 | 40.18 | 40.99 | 38.83 |
| Mar-5 | 40.45 | 39.90 | 40.66 | 39.50 |
| Mar-6 | 39.50 | 39.75 | 40.59 | 39.10 |
| Mar-7 | 39.74 | 38.04 | 40.17 | 37.91 |
| Mar-11 | 36.69 | 37.67 | 38.03 | 36.52 |
| Mar-12 | 38.25 | 39.31 | 39.83 | 37.81 |
| Mar-13 | 39.25 | 37.82 | 39.44 | 37.73 |
| Mar-14 | 38.00 | 38.67 | 39.20 | 37.84 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.03 per share, a decrease this year of $1.42 per share, and a decrease next year of $0.47 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.